Artiva Biotherapeutics, Inc. (ARTV) vs Eledon Pharmaceuticals, Inc. (ELDN)

Artiva Biotherapeutics, Inc. and Eledon Pharmaceuticals, Inc. are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Eledon Pharmaceuticals, Inc. are of similar size ($211.7M and $202.9M). Across the 8 metrics below, Artiva Biotherapeutics, Inc. leads on 6 and Eledon Pharmaceuticals, Inc. on 2.

Valuation

Metric ARTV ELDN Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.47 8.98 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.99 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (79.52%) (34.87%) (32.88%)
Free cash flow yield (47.02%) (24.90%) (23.13%)

Profitability

Metric ARTV ELDN Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.58%) (236.51%) (51.96%)
Return on assets (33.76%) (72.74%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARTV ELDN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 40.96% 30.67% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ARTV ELDN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 24.16 7.90 4.97
Net debt to EBITDA 1.24 1.60 1.01

Dividend

Metric ARTV ELDN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARTV ELDN Biotechnology median
Market cap 202.89m 211.69m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack